Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pateclizumab vs Adalimumab in Active Rheumatoid Arthritis
NCT01225393Phase 2Completed
- Sponsor
- Genentech
- Start
- Nov 2010
- Primary completion
- Jul 2012
- Modality
- Monoclonal Antibodies
- Countries
- 10
01
Overview
A Phase 2 trial of pateclizumab in rheumatoid arthritis (RA), sponsored by Genentech. Started Nov 2010; status: completed.
02
Drugs
pateclizumab
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT01225393.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01225393.